Indeed, although the molecular effectors vary across cancer types, and some mechanisms are not yet totally uncovered, METTL1-dependent m7G tRNA modification is essential for modulating cancer cell responses to stress and therapeutic challenges, being crucial for resistance acquisition. Here, METTL1 is linked to cancer.